STRATA Skin Sciences, Inc.
SSKN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $6,929 | $7,663 | $6,812 | $9,576 |
| % Growth | -9.6% | 12.5% | -28.9% | – |
| Cost of Goods Sold | $2,745 | $3,357 | $3,165 | $3,819 |
| Gross Profit | $4,184 | $4,306 | $3,647 | $5,757 |
| % Margin | 60.4% | 56.2% | 53.5% | 60.1% |
| R&D Expenses | $172 | $86 | $96 | $200 |
| G&A Expenses | $0 | $2,911 | $2,573 | $2,714 |
| SG&A Expenses | $5,869 | $6,444 | $5,566 | $5,923 |
| Sales & Mktg Exp. | $0 | $3,533 | $2,993 | $3,209 |
| Other Operating Expenses | $0 | $0 | $0 | $3,861 |
| Operating Expenses | $6,041 | $6,530 | $5,662 | $9,984 |
| Operating Income | -$1,857 | -$2,224 | -$2,015 | -$4,227 |
| % Margin | -26.8% | -29% | -29.6% | -44.1% |
| Other Income/Exp. Net | $235 | -$265 | -$417 | -$440 |
| Pre-Tax Income | -$1,622 | -$2,489 | -$2,432 | -$4,667 |
| Tax Expense | $0 | $0 | $0 | -$170 |
| Net Income | -$1,622 | -$2,489 | -$2,432 | -$4,497 |
| % Margin | -23.4% | -32.5% | -35.7% | -47% |
| EPS | -0.36 | -0.6 | -0.058 | -0.12 |
| % Growth | 40% | -929.2% | 51.4% | – |
| EPS Diluted | -0.36 | -0.6 | -0.058 | -0.12 |
| Weighted Avg Shares Out | 44,813 | 41,712 | 41,712 | 38,072 |
| Weighted Avg Shares Out Dil | 44,813 | 41,712 | 41,712 | 38,072 |
| Supplemental Information | – | – | – | – |
| Interest Income | $49 | $226 | $69 | $75 |
| Interest Expense | $498 | $491 | $486 | $515 |
| Depreciation & Amortization | $951 | $1,305 | $1,305 | $1,314 |
| EBITDA | -$173 | -$693 | -$641 | -$2,838 |
| % Margin | -2.5% | -9% | -9.4% | -29.6% |